Alexandria, Va. – The American Society of Clinical Oncology (ASCO) and The ASCO Cancer Foundation are honoring 10 community oncology practices for their efforts to improve care of people with cancer through participation in clinical trials. The Clinical Trials Participation Awards will be presented Sunday, June 1, 2008 at ASCO’s 44th Annual Meeting in Chicago.
Alexandria, Va.—The ASCO Cancer Foundation will award $7.6 million to support clinical and translational research designed to improve cancer prevention, treatment and care. The grants will be awarded to 62 researchers and three community oncology practices at the American Society of Clinical Oncology's 44th Annual Meeting in Chicago, May 31 – June 3.
Alexandria, Va.—In the first study to assess mammography in women 80 and older, researchers found that having regular mammograms significantly decreases the risk of being diagnosed with late-stage breast cancer, but only about one-fifth of women in this age group receive them regularly.
Alexandria, Va.- Next week marks the 20th anniversary of National Minority Cancer Awareness Week, established by Congress to bring attention to health disparities experienced by minority groups. The American Society of Clinical Oncology (ASCO) is developing tools and resources for improving access to care for people with cancer in underserved communities and increasing minority representation in the oncology workforce.
Alexandria, Va. – The physician who identified the BRCA1gene as an inherited mutation linked to breast cancer and the father of Tamoxifen, as he is known, are among the notable awardees set to be honored by the American Society of Clinical Oncology (ASCO) at their upcoming Annual Meeting.
Alexandria, Va. – The American Society of Clinical Oncology (ASCO) today launched Cancer.Net (www.cancer.net), a comprehensive, doctor-approved patient website that provides reliable, up-to-the-minute information on more than 120 types of cancer and cancer-related syndromes.
Alexandria, Va. — More than 30,000 cancer specialists from around the world will gather at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago to discuss the latest advances in cancer care, treatment, prevention and survivorship.
Alexandria, Va. —The American Society of Clinical Oncology (ASCO) has expanded its tools to improve documentation and coordination of cancer treatment and survivorship care by developing a “generic” chemotherapy treatment plan and summary template that can be customized for almost any cancer diagnosis.
Alexandria, Va.—A multicenter phase III clinical trial has reported that the drug letrozole cuts the risk of breast cancer recurrence by 63 percent and the risk of cancer spread by 61 percent in postmenopausal women with early-stage disease who completed five years of tamoxifen therapy one to seven years earlier. The study is being published online March 10 in the Journal of Clinical Oncology (JCO).
Alexandria, Va.—Douglas W. Blayney, MD, an internationally recognized expert in oncology quality and informatics, and hematologic malignancy, has been elected to become President of the American Society of Clinical Oncology (ASCO) for a one-year term beginning in June 2009. He will take office as President-Elect during ASCO’s 44th Annual Meeting in Chicago in June 2008. Additionally, four new members were elected to the ASCO Board of Directors and two new members to the ASCO Nominating Committee, all for three-year terms beginning in June 2008.
